Glass House Brands (GLAS) Share-based Compensation Growth (1y) (2021 - 2026)
Glass House Brands (GLAS) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Glass House Brands | 837.25 Mn | 818.69 Mn | 15.77 Mn | 43.14% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 114.87% |
| Dec 31, 2025 | 31.18% |
| Sep 30, 2025 | 38.41% |
| Jun 30, 2025 | -18.70% |
| Mar 31, 2025 | -35.67% |
| Dec 31, 2024 | 70.66% |
| Sep 30, 2024 | 14.88% |
| Jun 30, 2024 | 136.36% |
| Mar 31, 2024 | 100.60% |
| Dec 31, 2023 | -49.36% |
| Sep 30, 2023 | -8.76% |
| Jun 30, 2023 | -56.12% |
| Mar 31, 2023 | -39.18% |
| Dec 31, 2022 | 192.13% |
| Sep 30, 2022 | -8.74% |
| Jun 30, 2022 | 323.63% |
| Mar 31, 2022 | 66.95% |
| Dec 31, 2021 | -779.87% |
| Sep 30, 2021 | 390.55% |
| Jun 30, 2021 | 8.27% |